Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
An Overview on the Seven Pathogenic Human Coronaviruses Publisher Pubmed



Kesheh MM1 ; Hosseini P2, 3 ; Soltani S2, 3 ; Zandi M2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran

Source: Reviews in Medical Virology Published:2022


Abstract

To date, seven human coronaviruses (HCoVs) have been detected: HCoV-NL63, HCoV-229E, HCoV-HKU1, HCoV-OC43, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2. Four of these viruses, including HCoV-NL63, -229E, -HKU1 and -OC43, usually cause mild-to-moderate respiratory diseases with a seasonal pattern. Since 2000, three new HCoVs have emerged with a significant mortality rate. Although SARS-CoV and MERS-CoV caused an epidemic in some countries, SARS-CoV-2 escalated into a pandemic. All HCoVs can cause severe complications in the elderly and immunocompromised individuals. The bat origin of HCoVs, the presence of intermediate hosts and the nature of their viral replication suggest that other new coronaviruses may emerge in the future. Despite the fact that all HCoVs share similarities in viral replication, they differ in their accessory proteins, incubation period and pathogenicity. This study aims to review these differences between the seven HCoVs. © 2021 John Wiley & Sons Ltd.
Other Related Docs
10. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
11. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
12. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
16. Coronavirus, Its Neurologic Manifestations, and Complications, Iranian Journal of Pediatrics (2020)
17. Potential Antiviral Immune Response Against Covid-19: Lessons Learned From Sars-Cov, Advances in Experimental Medicine and Biology (2021)
20. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
22. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
23. A Review on Coronavirus Disease 2019 (Covid-19) in Pediatric Patients, Archives of Pediatric Infectious Diseases (2020)
26. The Role of Sars-Cov-2 Accessory Proteins in Immune Evasion, Biomedicine and Pharmacotherapy (2022)
27. The Role of Lipids in the Pathophysiology of Coronavirus Infections, Osong Public Health and Research Perspectives (2021)
30. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
34. The Role of Mirnas in Covid-19 Disease, Future Virology (2021)
42. Orf8a As a Viroporin in Sars-Cov-2 Infection?, Cytokine and Growth Factor Reviews (2021)
44. Precision Medicine in Infectious Disease, Precision Medicine in Clinical Practice (2022)
49. The Spike Protein Mutations and Its Effect on Sars-Cov-2 Pathogenesis, Journal of Cellular and Molecular Anesthesia (2021)